Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows a new revision tag (v3.6.3) replacing the previous v3.6.2, indicating a small maintenance update.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.2, signaling a small backend/template update rather than changes to the study information.SummaryDifference0.1%

- Check36 days agoChange DetectedRecruitment status now indicates the study is not enrolling; new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a standardized Intervention/Treatment heading with an updated Revision: v3.6.0 are added, while an older Intervention / Treatment heading and the previous revision label are removed.SummaryDifference0.4%

- Check44 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, marking a new version of the page. This appears to be an administrative update rather than a change to displayed information.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new revision of the page. This is a minor metadata update signaling a refreshed version rather than a substantive content change.SummaryDifference0.1%

- Check86 days agoChange DetectedThis updates the displayed ClinicalTrials.gov page revision/version from v3.5.2 to v3.5.3, indicating a site version refresh rather than any change to the underlying study details.SummaryDifference0.1%

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.